GlassScriptPhysician profile
Mark Allen Gerig
NPI 1972819811
$1,891.33
in general payments reported to CMS, 2019-2025
18 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $342 · 2021: $512 · 2022: $184 · 2023: $100 · 2024: $229 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $489.32 | 2019-2024 | Proclaim |
| Horizon Therapeutics Plc | $363.63 | 2019-2021 | |
| Zyla Life Sciences, INC. | $326.39 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $121.26 | 2024-2025 | |
| Smith+Nephew, INC. | $119.52 | 2019-2021 | |
| Orthofix Medical, INC. | $96.05 | 2023-2025 | Physio-Stim |
| Abbvie INC. | $76.21 | 2021-2025 | |
| Assertio Therapeutics, INC. | $69.56 | 2020 | |
| Treace Medical Concepts, INC. | $43.64 | 2024 | |
| Integra Lifesciences Corporation | $32.62 | 2021 | |
| Globus Medical, INC. | $30.91 | 2025 | Senza |
| Rattan and Associates | $20.37 | 2024 | |
| Melinta Therapeutics, LLC | $19.91 | 2021 | |
| Baudax Bio INC. | $18.26 | 2022 | |
| Averitas Pharma INC. | $17.75 | 2025 | Qutenza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.75 | 2021 | |
| Organogenesis INC. | $15.22 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.96 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gerig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.